EL-TRAN Consortium investigates what a resource efficiency means, how to implement such a system in Finland and elsewhere, what kind of policy problems are foreseeable in the process and how do we eventually resolve the problems. Consortium seeks answers to questions like:
The Consortium is coordinated by the University of Tampere. It is part of the programme ’A Climate-Neutral and Resource-Scarce Finland’. This programme is funded by the Strategic Research Council. Partners are: University of Tampere/School of Management, Tampere University of Technology/Department of Electrical Energy Engineering, University of Eastern Finland, Tampere University of Applied Sciences, University of Turku (UTU) and VTT Technical Research Centre of Finland (VTT).
Read more: https://el-tran.fi/in-english/
In ROSE we focus on the intersection of the two revolutions and the potential they create. Robots have gained more cognitive functions and improved safety, which has made it possible to use robots for providing completely new types of services. The use of robots in providing health and welfare services is in our reach as recognized also by the European Union’s strong commitment to developing the area. Health and welfare services cover the majority of public expenditure in Finland and this is rising due to demographic changes, especially the aging population.
Research funded by The Academy of Finland is coordinated by Aalto University. Partners are from Tampere University of Technology (Department of Signal Processing), University of Tampere (The School of Social Sciences and Humanities), Lappeenranta University of Technology, Laurea University of Applied Sciences and VTT Technical Research Centre of Finland Ltd.
Human Spare Parts is a research program hosted by BioMediTech Research Institute, which in turn is run by the University of Tampere, Finland, and the Tampere University of Technology, Finland. The Human Spare Parts program began in 2011, although joint research activities in the area of regenerative medicine and supporting technologies have been ongoing prior to this for several years. Our goal is to study and develop stem cell based solutions for tissue defects, and find new treatments for bone, neural, retinal and cardiac diseases and traumas. With over 25 treated patients and the largest bone deficiency treatments in the world, we are the forerunners in stem cell research.
Read more: http://humanspareparts.fi/